Journal of Chinese Integrative Medicine ›› 2003, Vol. 1 ›› Issue (1): 25-29.doi: 10.3736/jcim20030111
Previous Articles Next Articles
Zhao-shan Chen1(), Yao-rong Dong1, Wan-ying Hu2
CLC Number:
[1] |
Ho KK, Pinsky JL, Kannel WB , et al. The epidemiology of heart failure: the Framingham Study[J]. J Am Coll Cardiol, 1993,22(4 Suppl A):6A-13A
doi: 10.1016/0735-1097(93)90455-A pmid: 8376698 |
[2] | Lee DC, Johnson RA, John B , et al. Heart failure in outpatients[J]. New England J Med, 1982,12(306):699-705 |
[3] | 沈自尹 . 中医虚证辨证标准[J]. 中西医结合杂志, 1986,5(10):698 |
[4] |
Devereux RB, Alonso DR, Lutas EM , et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings[J]. Am J Cardiol, 1986,57(15):450-458
doi: 10.1016/0002-9149(86)90771-X pmid: 2936235 |
[5] |
Schwartz SM, Duffy JY, Pearl JM , et al. Cellular and molecular aspects of myocardial dysfunction[J]. Crit Care Med, 2001,29(10 Suppl):S214-219
doi: 10.1097/00003246-200110001-00003 pmid: 11593064 |
[6] |
Ferrari R, Bachetti T . Endothelial dysfunction and heart failure[J]. Ital Heart J, 2001,2(Suppl):45S-47S
pmid: 11593933 |
[7] |
Barton M, Kiowski W . The therapeutic potential of endothelin receptor antagonists in cardiovascular disease[J]. Curr Hypertens Rep, 2001,3(4):322-330
doi: 10.1007/s11906-001-0095-6 pmid: 11470015 |
[8] |
Lombardi WL, Gilbert EM . The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure[J]. Curr Cardiol Rep, 2000,2(2):90-98
doi: 10.1007/s11886-000-0004-7 |
[9] |
Delgado RM 3rd, Willevson JT . Pathophysiology of heart failure:a look at the future[J]. Texas Heart Inst J, 1999,26(1):28-32
doi: 10.1016/S0029-8018(01)00015-4 pmid: 10217468 |
[10] |
Jackson G, Gibbs CR, Davies Mk , et al. ABC of heart failure pathophysiology[J]. BMJ, 2000,320(7228):167-170
doi: 10.1136/bmj.320.7228.167 pmid: 1128747 |
|